Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas
Clinical trial NCT02829931 · COMPLETED
Trial details
- NCT number
- NCT02829931
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-22
- Primary completion
- 2021-08-11
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.